Every one of those 1 sits in a single category, funding. Of the tracked stories, 1 of 1 also mention Aureka Biotechnologies, the most common co-covered peer. The tracked stories average 2 original sources each. Granite Asia appears in 1 tracked AI story from August 11, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Granite Asia
Every one of those 1 sits in a single category, funding. Of the tracked stories, 1 of 1 also mention Aureka Biotechnologies, the most common co-covered peer. The tracked stories average 2 original sources each. Granite Asia appears in 1 tracked AI story from August 11, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 9 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Granite Asia. Shared-story counts are live from our verified record — not editorial picks.
AI-native biotech Aureka Biotechnologies raised $100M in Series B to scale its biological foundation models and closed-loop experimentation platform. The company aims to build a ‘biological world model’—a generalist AI that learns the rules of biology, moving beyond narrow task-specific applications.